Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Thilaganathan 1999.

Clinical features and settings Routine screening
Participants 9802 participants
UK ‐ district general hospital
November 1994 to November 1998
Pregnant women
Singleton pregnancies
Mean age 29 years (15‐45 years)
10 to 14 weeks' gestation
Study design Prospective cohort
Target condition and reference standard(s) Down's syndrome: 21 cases
Reference standards: CVS (offered to patients considered high risk on screening) or follow‐up to birth
Index and comparator tests Maternal age
First trimester NT (transabdominally, Toshiba SSA‐250, Accuson 128XP/4 or Aloka 650CL with 3.5‐7.5 curvilinear transducers)
Follow‐up Pregnancy outcomes from hospital records and general practitioners. Karyotype results or postnatal tests were provided by the local Regional Cytoenetics laboratory. The proportion of patients who were followed up is not reported (49 patients had not given birth at the time of analysis of outcomes)
Aim of study To evaluate the effectiveness of 10‐14 week NT measurement in routine ultrasounds screening for Down's syndrome
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population 
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Unclear Unclear if all women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice 
Uninterpretable results reported? 
 All tests Yes Unsuccessful NT in 10.1% of patients
Withdrawals explained? 
 All tests Yes Patients not included due to ineligibility described